The US Food and Drug Administration (FDA) has confirmed that anaplastic large cell lymphoma (ALCL) is a rare but real risk associated with breast implants. The FDA had recognised a possible association in 2011 but at the time concluded that more information was needed. Since then, the World Health Organization formally designated such cases as ...
Breast implant-related lymphoma risk confirmed by FDA
31 Mar 2017